Abstract
Multiple myeloma, a plasma-cell neoplasm characterized by skeletal destruction, renal failure, anemia, and hypercalcemia, remains incurable. However, recent advances in its treatment, in particular, the use of thalidomide and such new drugs as bortezomib and CC-5013, are promising. This article discusses current therapy for multiple myeloma.
Citation impact
1,277
total citations
- FWCI
- 37.03
- Percentile
- 100%
- References
- 92
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Medicine
- Multiple myeloma
- Thalidomide
- Bortezomib
- Plasma cell neoplasm
- Lenalidomide
- Anemia
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.